We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mixed Victory For Pfizer In Dutch Lipitor Battle

Law360 (September 13, 2006, 12:00 AM EDT) -- Pharmaceutical giant Pfizer Inc. has received another victory in its battle to protect Lipitor from generic reproduction, after a Dutch court ruled Ranbaxy Laboratories Ltd.’s version of the cholesterol drug would violate a Pfizer patent.

Pfizer said in a statement Wednesday that the District Court of The Hague in the Netherlands ruled that the basic patent for Lipitor would be infringed by Ranbaxy’s product. A second patent, however, was struck down.

The decision from the court’s three-judge panel prevents India-based Ranbaxy from launching a Dutch version...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.